Research programme: TLR9 agonists - Pfizer

Drug Profile

Research programme: TLR9 agonists - Pfizer

Alternative Names: CpG 10104; CpG-ODN; TLR9 agonists research programme - Pfizer; Toll-like receptor 9 agonists - Pfizer

Latest Information Update: 22 Jul 2010

Price : $50

At a glance

  • Originator Coley Pharmaceutical Group
  • Class
  • Mechanism of Action Toll-like receptor 9 agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • On Fast track

    Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.


Highest Development Phases

  • Preclinical Cancer; Viral infections

Most Recent Events

  • 13 Aug 2009 This programme is still in active development
  • 01 Apr 2004 Preclinical trials in Cancer in USA (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top